Nicole Chase, MD, leads a panel of medical professionals highlighting critical aspects of asthma exacerbation and treatment management.
EP. 3: Type 2 Inflammation and Biomarkers in Asthma
May 15th 2024The panelists explore the significance of type 2 inflammation in asthma, including its role and associated markers, while also delving into their approach to assessing patients whose asthma is triggered or worsened by allergies, examining markers beyond IgE and noting the frequency of patients presenting with asthma symptoms during allergy season without actually having allergic asthma.
EP. 4: Moderate/Severe/Uncontrolled Asthma Classification
May 15th 2024The key opinion leaders deliberate on the criteria used to classify a patient as having moderate or severe asthma, as well as the factors that determine when a patient's asthma is deemed uncontrolled—including the use of combination therapy and daily symptoms.